^
    BIOMARKER:

    MYD88 L265P

    i
    Other names: MYD88, MYD88 Innate Immune Signal Transduction Adaptor, Myeloid Differentiation Primary Response Protein MyD88, Myeloid Differentiation Primary Response Gene (88), Myeloid Differentiation Primary Response 88, Mutant Myeloid Differentiation Primary Response 88, MYD88D
    Entrez ID:
    4615
    Related biomarkers:
    Expression
    Mutation
    MYD88 L265P
    Waldenstrom Macroglobulinemia
    zanubrutinib
    Sensitive: B - Late Trials
    MYD88 L265P
    Waldenstrom Macroglobulinemia
    rituximab + ixazomib
    Sensitive: C2 – Inclusion Criteria
    MYD88 L265P
    Lymphoma
    ibrutinib
    Sensitive: C2 – Inclusion Criteria
    MYD88 L265P
    Waldenstrom Macroglobulinemia
    venetoclax
    Sensitive: C3 – Early Trials
    MYD88 L265P
    Marginal Zone Lymphoma
    ibrutinib
    Sensitive: C3 – Early Trials
    MYD88 L265P
    Waldenstrom Macroglobulinemia
    daratumumab
    Sensitive: C3 – Early Trials
    MYD88 L265P
    Diffuse Large B Cell Lymphoma
    rituximab
    Resistant: C3 – Early Trials
    MYD88 L265P
    Waldenstrom Macroglobulinemia
    X4P-001
    Sensitive: C3 – Early Trials
    MYD88 L265P
    Waldenstrom Macroglobulinemia
    orelabrutinib
    Sensitive: C3 – Early Trials
    MYD88 L265P
    NHL
    rituximab
    Resistant: C3 – Early Trials
    MYD88 L265P
    Multiple Myeloma
    lenalidomide + bortezomib
    Sensitive: C4 – Case Studies
    MYD88 L265P
    Diffuse Large B Cell Lymphoma
    KT-413
    Sensitive: D – Preclinical